Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Sequence features governing aggregation or degradation of prion-like proteins.

Cascarina SM, Paul KR, Machihara S, Ross ED.

PLoS Genet. 2018 Jul 13;14(7):e1007517. doi: 10.1371/journal.pgen.1007517. eCollection 2018 Jul.

2.

Manipulating the aggregation activity of human prion-like proteins.

Cascarina SM, Paul KR, Ross ED.

Prion. 2017 Sep 3;11(5):323-331. doi: 10.1080/19336896.2017.1356560.

3.

Effects of Mutations on the Aggregation Propensity of the Human Prion-Like Protein hnRNPA2B1.

Paul KR, Molliex A, Cascarina S, Boncella AE, Taylor JP, Ross ED.

Mol Cell Biol. 2017 Mar 31;37(8). pii: e00652-16. doi: 10.1128/MCB.00652-16. Print 2017 Apr 15.

4.

Controlling the prion propensity of glutamine/asparagine-rich proteins.

Paul KR, Ross ED.

Prion. 2015;9(5):347-54. doi: 10.1080/19336896.2015.1111506.

5.

Generating new prions by targeted mutation or segment duplication.

Paul KR, Hendrich CG, Waechter A, Harman MR, Ross ED.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8584-9. doi: 10.1073/pnas.1501072112. Epub 2015 Jun 22.

6.

Distinct amino acid compositional requirements for formation and maintenance of the [PSI⁺] prion in yeast.

MacLea KS, Paul KR, Ben-Musa Z, Waechter A, Shattuck JE, Gruca M, Ross ED.

Mol Cell Biol. 2015 Mar;35(5):899-911. doi: 10.1128/MCB.01020-14. Epub 2014 Dec 29.

7.

Increasing prion propensity by hydrophobic insertion.

Gonzalez Nelson AC, Paul KR, Petri M, Flores N, Rogge RA, Cascarina SM, Ross ED.

PLoS One. 2014 Feb 20;9(2):e89286. doi: 10.1371/journal.pone.0089286. eCollection 2014.

8.

De novo design of synthetic prion domains.

Toombs JA, Petri M, Paul KR, Kan GY, Ben-Hur A, Ross ED.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6519-24. doi: 10.1073/pnas.1119366109. Epub 2012 Apr 2.

9.

Letter: malabsorption syndrome.

Chakraborty P, Sen D, Paul KR.

J Indian Med Assoc. 1974 May 1;62(9):329. No abstract available.

PMID:
4436553

Supplemental Content

Support Center